Liger Medical

Liger Medical is a US-based small business focused on providing cutting-edge medical equipment and solutions for the prevention and treatment of cervical cancer and precancerous lesions. The company designs single-purpose, user-friendly devices based on World Health Organization guidelines for cervical cancer screening and treatment in resource-limited and developed healthcare settings. Founded by Dr. Wm. Dean Wallace (MD, PhD) with over 50 years of medical device development experience, Liger Medical manufactures thermocoagulation systems, electrosurgical generators, and digital colposcope platforms engineered for ease of use, reliability, and safety. Their product portfolio includes the TC Thermocoagulator, ESU-110 Electrosurgical Generator, IRIS (integrated thermocoagulator and digital colposcope), EVA Pro, and EVA SafeView. These devices enable healthcare providers—including family practitioners, OB/GYN specialists, nurses, and midwives—to perform cervical cancer screening, diagnosis, and ablative treatment of cervical intraepithelial neoplasia (CIN). The company serves global markets, with documented use in humanitarian and clinical settings across Africa, Asia, and North America. Products emphasize portability, battery efficiency, minimal training requirements, and cost-effectiveness to support cervical cancer elimination initiatives. Liger Medical is committed to partnerships with the WHO and humanitarian groups to expand access to cervical cancer prevention and treatment technologies worldwide.